{"entity":{"type":"insider","cik":"0001713637","url":"/insider/0001713637","json_url":"/insider/0001713637.json","name":"Ho Tony W","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":3,"first":"2020-05-27","last":"2020-12-22","span_basis":"filed_date"},"name_variants":[{"name":"Ho Tony W","source":"filing","n_filings":3,"first_seen":"2020-05-27","last_seen":"2020-12-22"}],"transactions":[{"id":3262160,"accession":"0001209191-20-064857","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-20-064857","line_url":"/filing/0001209191-20-064857","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001713637","owner_name":"Ho Tony W","owner_display_name":"Ho Tony W","owner_url":"/insider/0001713637","role":"Officer (Executive VP, Head of R&D)","role_mark":"O","role_mark_label":"Officer (Executive VP, Head of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP, Head of R&D","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23551.0,"shares_display":"23,551","price_per_share":149.23400747314338,"price_display":"149.23","price_state":"stated","total_value":3514610.11,"total_display":"3,514,610.11","total_whole":"3,514,610","shares_owned_after":41915.0,"shares_owned_after_display":"41,915","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-21","filed_date":"2020-12-22","scope":"insider","n_lines":9},{"id":3278613,"accession":"0001209191-20-038761","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-038761","line_url":"/filing/0001209191-20-038761#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001713637","owner_name":"Ho Tony W","owner_display_name":"Ho Tony W","owner_url":"/insider/0001713637","role":"Officer (Executive VP, Head of R&D)","role_mark":"O","role_mark_label":"Officer (Executive VP, Head of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP, Head of R&D","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6929.0,"shares_display":"6,929","price_per_share":75.2,"price_display":"75.20","price_state":"stated","total_value":521060.8,"total_display":"521,060.80","total_whole":"521,061","shares_owned_after":33747.0,"shares_owned_after_display":"33,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-24","scope":"insider"},{"id":3278608,"accession":"0001209191-20-038761","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-038761","line_url":"/filing/0001209191-20-038761#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001713637","owner_name":"Ho Tony W","owner_display_name":"Ho Tony W","owner_url":"/insider/0001713637","role":"Officer (Executive VP, Head of R&D)","role_mark":"O","role_mark_label":"Officer (Executive VP, Head of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP, Head of R&D","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":229.0,"shares_display":"229","price_per_share":70.14,"price_display":"70.14","price_state":"stated","total_value":16062.06,"total_display":"16,062.06","total_whole":"16,062","shares_owned_after":40676.0,"shares_owned_after_display":"40,676","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-22","filed_date":"2020-06-24","scope":"insider"},{"id":2246792,"accession":"0001209191-20-032312","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-032312","line_url":"/filing/0001209191-20-032312#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001713637","owner_name":"Ho Tony W","owner_display_name":"Ho Tony W","owner_url":"/insider/0001713637","role":"Officer (Executive VP, Head of R&D)","role_mark":"O","role_mark_label":"Officer (Executive VP, Head of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP, Head of R&D","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6100.0,"shares_display":"6,100","price_per_share":70.14,"price_display":"70.14","price_state":"stated","total_value":427854.0,"total_display":"427,854.00","total_whole":"427,854","shares_owned_after":40905.0,"shares_owned_after_display":"40,905","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-26","filed_date":"2020-05-27","scope":"insider"},{"id":2246790,"accession":"0001209191-20-032312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-032312","line_url":"/filing/0001209191-20-032312#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001713637","owner_name":"Ho Tony W","owner_display_name":"Ho Tony W","owner_url":"/insider/0001713637","role":"Officer (Executive VP, Head of R&D)","role_mark":"O","role_mark_label":"Officer (Executive VP, Head of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP, Head of R&D","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":70.05,"price_display":"70.05","price_state":"stated","total_value":42030.0,"total_display":"42,030.00","total_whole":"42,030","shares_owned_after":47005.0,"shares_owned_after_display":"47,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-22","filed_date":"2020-05-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001674416","name":"CRISPR Therapeutics AG","url":"/issuer/0001674416","role":"Officer (Executive VP, Head of R&D)","n_filings":3,"first_seen":"2020-05-27","last_seen":"2020-12-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001713637","retrieved_at":"2026-08-24T13:14:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}